title: Bioactivity of isoflavones: assessment through a theoretical model as a way to obtain a "Theoretical Efficacy Related to Estradiol (TERE)".
abstract: The increase of human life span will have profound implications in Public Health in decades to come. By 2030, there will be an estimated 1.2 billion women in post-menopause. Hormone Replacement Therapy with synthetic hormones is still full of risks and according to the latest developments, should be used for the shortest time possible. Searching for alternative drugs is inevitable in this scenario and science must provide physicians with other substances that can be used to treat the same symptoms with less side effects. Systematic research carried out on this field of study is focusing now on isoflavones but the randomised controlled trials and reviews of meta-analysis concerning post-menopause therapy, that could have an important impact on human health, are very controversial. The aim of the present work was to establish a theoretical calculation suitable for use as a way to estimate the "Theoretical Efficacy (TE)" of a mixture with different bioactive compounds as a way to obtain a "Theoretical Efficacy Related to Estradiol (TERE)". The theoretical calculation that we propose in this paper integrates different knowledge about this subject and sets methodological boundaries that can be used to analyse already published data. The outcome should set some consensus for new clinical trials using isoflavones (isolated or included in mixtures) that will be evaluated to assess their therapeutically activity. This theoretical method for evaluation of a possible efficacy could probably also be applied to other herbal drug extracts when a synergistic or contradictory bio-effect is not verified. In this way, it we may contribute to enlighten and to the development of new therapeutic approaches.
authors.affiliation: Center of Pharmaceutical Studies, University of Coimbra, Azinhaga de Santa Comba, Coimbra, Portugal. mgcampos@ff.uc.pt <mgcampos@ff.uc.pt>
authors.forename: Maria
authors.initials: M
authors.lastname: da Graça R Campos
authors.forename: Miguel Pires
authors.initials: MP
authors.lastname: Matos
mesh_terms: D016208:Databases, Factual; D004958:Estradiol / Q000737:chemistry / Q000378:metabolism*; D005260:Female; D006801:Humans; D007529:Isoflavones / Q000737:chemistry / Q000378:metabolism*; D008962:Models, Theoretical; D011485:Protein Binding; D011960:Receptors, Estrogen / Q000378:metabolism; D013025:Glycine max / Q000737:chemistry / Q000378:metabolism
chemical_list: D007529:Isoflavones; D011960:Receptors, Estrogen; D004958:Estradiol
references.citation: Nutr Cancer. 1997;28(3):236-47
references.pmid: 9343831
references.citation: Maturitas. 2003 Mar 14;44 Suppl 1:S21-9
references.pmid: 12609556
references.citation: Maturitas. 2004 Aug 20;48(4):372-80
references.pmid: 15283929
references.citation: Vasc Med. 2004 Feb;9(1):26-30
references.pmid: 15230485
references.citation: Lancet. 1999 Oct 2;354(9185):1184
references.pmid: 10513722
references.citation: BMJ. 2001 Aug 11;323(7308):334-6
references.pmid: 11498496
references.citation: JAMA. 2004 Jul 7;292(1):65-74
references.pmid: 15238592
references.citation: Menopause. 2004 Jul-Aug;11(4):400-4
references.pmid: 15243277
references.citation: Am J Clin Nutr. 2005 Jan;81(1):5-6
references.pmid: 15640453
references.citation: Eur J Clin Nutr. 2003 Aug;57(8):889-94
references.pmid: 12879082
references.citation: Am J Med. 2003 Apr 15;114(6):470-6
references.pmid: 12727580
references.citation: Carcinogenesis. 2006 Jun;27(6):1292-9
references.pmid: 16537557
references.citation: Am J Clin Nutr. 2004 Feb;79(2):326-33
references.pmid: 14749241
references.citation: Atherosclerosis. 2002 Aug;163(2):339-47
references.pmid: 12052481
references.citation: Proc Nutr Soc. 2006 Feb;65(1):76-92
references.pmid: 16441947
references.citation: J Clin Endocrinol Metab. 1999 Mar;84(3):895-8
references.pmid: 10084567
references.citation: Am J Clin Nutr. 1984 Sep;40(3):569-78
references.pmid: 6383008
references.citation: J Clin Oncol. 2002 Jul 1;20(13):3040-1; author reply 3041-2
references.pmid: 12089239
references.citation: Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):1066-71
references.pmid: 12714433
references.citation: Inflammopharmacology. 2008 Oct;16(5):227-9
references.pmid: 18815739
references.citation: Menopause. 2006 Sep-Oct;13(5):831-9
references.pmid: 16932241
references.citation: Chem Biol. 2004 Mar;11(3):397-406
references.pmid: 15123269
references.citation: Food Chem Toxicol. 2000 Jul;38(7):555-64
references.pmid: 10942316
references.citation: Am J Clin Nutr. 2003 Jul;78(1):123-30
references.pmid: 12816781
references.citation: J Bone Miner Res. 2002 Oct;17(10):1904-12
references.pmid: 12369794
references.citation: Lancet. 2000 Jan 15;355(9199):163-4
references.pmid: 10675113
references.citation: Obstet Gynecol. 1988 Nov;72(5):688-92
references.pmid: 3140150
references.citation: EMBO J. 1999 Sep 1;18(17):4608-18
references.pmid: 10469641
references.citation: J Clin Endocrinol Metab. 2001 Jul;86(7):3053-60
references.pmid: 11443167